These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 7666904
21. Early patency in acute myocardial infarction. Belenkie I. Can J Cardiol; 1993 Mar; 9(2):149-51. PubMed ID: 8490781 [No Abstract] [Full Text] [Related]
22. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E, Degli Esposti D. Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [Abstract] [Full Text] [Related]
23. [Thrombolytic therapy of acute myocardial infarction]. Chen JL. Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):69-70. PubMed ID: 15808085 [No Abstract] [Full Text] [Related]
24. [Fibrinolytic treatment of myocardial infarction. Introduction]. Kawecka-Jaszcz K. Przegl Lek; 1992 Jan 05; 49(9):310-11. PubMed ID: 1302357 [No Abstract] [Full Text] [Related]
25. [New thrombolytic agents in myocardial infarction]. Charbonnier B, Lang M, Brochier M. Arch Mal Coeur Vaiss; 1987 Nov 05; 80(12):1785-91. PubMed ID: 3128222 [Abstract] [Full Text] [Related]
26. Thrombolytic therapy for acute myocardial infarction in the elderly. Straznicky IT, White HD. Coron Artery Dis; 2000 Jun 05; 11(4):299-304. PubMed ID: 10860172 [No Abstract] [Full Text] [Related]
28. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?]. Negrini M. G Ital Cardiol; 1995 Apr 05; 25(4):511-5. PubMed ID: 7677921 [No Abstract] [Full Text] [Related]
29. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent? Handlin LR, Vacek JL. Postgrad Med; 1994 Mar 05; 95(4):77-82. PubMed ID: 8121861 [Abstract] [Full Text] [Related]
31. [My practice of thrombolysis in the acute phase of myocardial infarction in the light of extensive studies]. Bory M. Ann Cardiol Angeiol (Paris); 1992 Dec 05; 41(10):595-7. PubMed ID: 1300923 [Abstract] [Full Text] [Related]
34. Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarction. Kluft C, Munkvad S, Gram J, Jespersen J. Agents Actions Suppl; 1992 Jun 05; 38 ( Pt 2)():299-304. PubMed ID: 1462835 [No Abstract] [Full Text] [Related]
35. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. Kalish SC, Gurwitz JH, Krumholz HM, Avorn J. J Gen Intern Med; 1995 Jun 05; 10(6):321-30. PubMed ID: 7562123 [Abstract] [Full Text] [Related]
36. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents. Woo KS, White HD. Pharmacoeconomics; 1993 Mar 05; 3(3):192-204. PubMed ID: 10172049 [Abstract] [Full Text] [Related]
38. Economic and cost-effectiveness in evaluating the value of cardiovascular therapies. The impact of the cost-effectiveness study of GUSTO-1 on decision making with regard to fibrinolytic therapy. Califf RM, Stump D, Topol EJ, Mark DB. Am Heart J; 1999 May 05; 137(5):S90-3. PubMed ID: 10220606 [No Abstract] [Full Text] [Related]